Keyword: Food and Drug Administration (FDA)
News
08.02.2016
- European regulators have approved a lung cancer drug from UK-Swedish drug maker AstraZeneca. Tagrisso was the first new drug to win accelerated approval by the European Medicines...
News
02.02.2016
- The US Food and Drug Administration (FDA) has granted priority review to US drug maker Merck & Co for bezlotoxumab, an antitoxin for preventing the recurrence of Clostridium...
News
01.02.2016
- The US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) to UK-Swedish drug maker AstraZeneca for its oral poly ADP-ribose polymerase (PARP)...
News
29.01.2016
- The US Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) submitted by UK-Swedish drugmaker AstraZeneca in partnership with Canadian...
Research & Innovation
29.01.2016
- Time is money; this holds particularly true for drug research and development. The global pharmaceutical industry spends about $100 billion a year on R&D. Researchers are...
News
13.01.2016
- Five major internationally active drugmakers, including American biotech firms Amgen and Celgene, along with pharmaceutical giant Pfizer and non-US players such as Glaxo SmithKline...
News
07.01.2016
- Germany’s Merck KGaA and Pfizer of the US are collaborating with US biopharmaceutical company Syndax to evaluate a combination of avelumab and entinostat to treat advanced ovarian...
News
07.01.2016
- The US Food and Drug Administration (FDA) said it will ban three perfluorinated compounds (PFCs) used in food packaging that have been linked to cancer and birth defects. The ban...
